KliFOs is an ambulatory Site Management Organization (SMO) in the center of Osnabrück. We carry out clinical trials phase II, III, and IV for the pharmaceutical industry and contract research organizations (CROs).

KliFOs specializes in dermatologic studies. Dr. Bunselmeyer, the managing director and former head of the clinical trial center of the Department of Dermatology, University Hospital Münster (Director: Prof. Dr. med. Dr. h.c. Thomas Luger), has conducted over 100 clinical trials in the field of psoriasis, atopic dermatitis and other dermatological indications together with her team of researchers and study nurses. Close cooperation with medical specialists from various disciplines enables KliFOs to carry out studies in many areas, such as Allergology, and Pneumology.

We guarantee a fast and efficient patient recruitment through our dynamic network with specialized medical practices and clinics, a comprehensive patient data base and professional advertisement. Our experienced study team undertakes refresher ICH-GCP training on a regular basis, which guarantees high quality data documentation.

KliFOs comes with modern communication tools and has experience with electronic data capture (eCRFs), phone-, and internet based randomization tools, such as IVRS. The controlled storage of investigational drugs is ensured by an alert-based temperature monitoring. Data security has high priority for us. We work conform with the general data protection regulation and the german data protection law (GDPR / BDSG) and we guarantee the safety, confidentiality, integrety and availability of data. ist. Our data protection management system is controlled by an external data security officer. 

Our medical and administrative study staff will support your clinical research associates (CRAs) with utmost privacy and attention.

We are subject to monitoring obligation by the regulatory authorities (State Labour Inspectorate Oldenburg). GCP control inspection by the regulatory authorities (State Labour Inspectorate Oldenburg) on 31.08.2015 and 01.09.2015. Result: No critical and no serious findings, only minor ones. Excerpt from the inspection report: "The site KliFOs in Osnabrück is due to its facilities and staffing suitable to conduct clinical trials with drugs. In particular, the good organizational structure resulted in a high GCP-compliance and a small number of deviations. The great commitment of the Managing Director and the employees is worth emphasizing."

We guarantee a thorough, prompt and comprehensive answer to your query.

Please contact us! We look forward to meeting you!